Picture of BLS Pharmaceuticals logo

BXNDA BLS Pharmaceuticals News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapHigh Flyer

Brief: Bioxyne Updates On Australian Medicinal Cannabis Business

Oct 19 (Reuters) - Bioxyne Ltd  BXN.AX :
    * UNIT IMPORTED AND IRRADIATED A FURTHER 200KG OF PREMIUM
HIGH THC
CANNABIS FLOWER ACROSS FOUR STRAINS INTO AUSTRALIA
    * BLS HAS IMPORTED 200KG OF PREMIUM HIGH THC CANNABIS FLOWER
WORTH
AROUND A$3.2M

Source text for Eikon:  ID:nASX87gjSD 
Further company coverage:  BXN.AX 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BLS Pharmaceuticals

See all news